Pneumocystis Jirovecii Infection clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Prospective Observational Study on the Incidence of Opportunistic Fungal Infections
Sorry, not yet accepting patients
Corticosteroids exposure is a common risk factor for invasive fungal infections. Systemic corticosteroid therapy treats several medical conditions, including rejection in solid organ transplant recipients, malignancy, and autoimmune or inflammatory diseases. Corticosteroid exposure is a well-known risk factor for developing PJP. Still, it remains unclear how prior corticosteroid exposure influences the presentation, severity, and mortality of opportunistic fungal infections. The investigators aim to prospectively characterize the corticosteroid use as a dose response to inform risk of invasive fungal infections.
at UC Davis